An invisible barrier separates land animals in Australia from those in south-east Asia may also restrict the spillover of animal-borne diseases like avian flu, but researchers have found that fruit bats on either side of this line can carry Nipah virus, a pathogen that causes severe human disease. The findings are published April 24 in the open access journal PLOS ONE by Andrew Breed from the University of Queensland, Australia and colleagues from other institutions.
Previous studies have suggested that this biogeographic boundary, named Wallace's line, may have played a role in protecting Australia from the spread of the avian flu H5N1. In the current study, researchers assessed whether this boundary could restrict the distribution of Nipah virus, which has caused severe outbreaks of human and domestic animal disease in the past.
"We found evidence that Nipah Virus occurs on the eastern side of Wallace's Line and much closer to Australia than previously recognized," says Breed. "We also found that the epidemiology of Nipah virus, and related viruses, is complex and these viruses are not restricted to flying-foxes (Pteropus bats) in this region."
They found that fruit bats from regions on both sides of the line tested positive for Nipah virus and other related viruses called henipaviruses. Only certain species of fruit bats carried Nipah virus but even in their absence, other bat species could still carry these related viruses. Henipaviruses were also detected in some species not previously known to carry these viruses. Based on these results, the authors conclude that Wallace's line is not a restricting factor for the transmission of Nipah virus. Their results also extend the known regions where Nipah virus has been detected by over 2500 km, to the island of Timor.
Citation: Breed AC, Meers J, Sendow I, Bossart KN, Barr JA, et al. (2013) The Distribution of Henipaviruses in Southeast Asia and Australasia: Is Wallace's Line a Barrier to Nipah Virus? PLoS ONE 8(4): e61316. doi:10.1371/journal.pone.0061316
Financial Disclosure: The authors acknowledge support from the Australian Biosecurity CRC for Emerging Infectious Disease; the Henipavirus Ecology Research Group (HERG), funded in part by an National Institutes of Health/National Science Foundation ''Ecology of Infectious Diseases'' award from the John E. Fogarty International Center R01-TW05869; and the European Commission Seventh Framework Programme under ANTIGONE with project number 278976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interest Statement: The authors have declared that no competing interests exist.
PLEASE LINK TO THE SCIENTIFIC ARTICLE IN ONLINE VERSIONS OF YOUR REPORT (URL goes live after the embargo ends): http://dx.
Disclaimer: This press release refers to upcoming articles in PLOS ONE. The releases have been provided by the article authors and/or journal staff. Any opinions expressed in these are the personal views of the contributors, and do not necessarily represent the views or policies of PLOS. PLOS expressly disclaims any and all warranties and liability in connection with the information found in the release and article and your use of such information.
About PLOS ONE: PLOS ONE is the first journal of primary research from all areas of science to employ a combination of peer review and post-publication rating and commenting, to maximize the impact of every report it publishes. PLOS ONE is published by the Public Library of Science (PLOS), the open-access publisher whose goal is to make the world's scientific and medical literature a public resource.
All works published in PLOS ONE are Open Access. Everything is immediately available--to read, download, redistribute, include in databases and otherwise use--without cost to anyone, anywhere, subject only to the condition that the original authors and source are properly attributed. For more information about PLOS ONE relevant to journalists, bloggers and press officers, including details of our press release process and our embargo policy, see the everyONE blog at http://everyone.